Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

JOHNSON & JOHNSON : Credit Suisse gives a Buy rating

10/13/2020 | 11:13am EDT

Credit Suisse is positive on the stock with a Buy rating. The target price remains unchanged at USD 163.


ę MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
CREDIT SUISSE GROUP AG -0.32% 9.374 Delayed Quote.-17.51%
JOHNSON & JOHNSON -0.13% 163.62 Delayed Quote.3.96%
All news about JOHNSON & JOHNSON
02:35pHALOZYME THERAPEUTICSá : Says Janssen's Darzalex Gets Two Marketing Authorizatio..
MT
12:25pInsulin pump Accessories Market Development, Outline, Competitive perspective..
AQ
10:53aGENMAB A/Sá : Partner Janssen Secures EU Approval for Darzalex SC Combo in Rare ..
MT
09:50aLEGEND BIOTECHá : Johnson & Johnson Unit to Build Manufacturing Facility in Belg..
MT
06:06aJOHNSON & JOHNSONá : Economic Support Needed to Aid Post-Pandemic Recovery
AQ
06/21JOHNSON & JOHNSONá : How Johnson & Johnson Helped Us Adopt 11 Children
AQ
06/19MODERNAá : U.S. administers more than 317 mln doses of COVID-19 vaccines - CDC
RE
06/18The Week Ahead -- Barron's
DJ
06/17JOHNSON & JOHNSONá : Eying border reopening, Mexico begins J&J vaccine rollout i..
AQ
06/17Canada Vaccine Panel Recommends Against AstraZeneca PLC for Second Dose
DJ
More news
Financials (USD)
Sales 2021 92 812 M - -
Net income 2021 22 227 M - -
Net Debt 2021 314 M - -
P/E ratio 2021 19,7x
Yield 2021 2,55%
Capitalization 431 B 431 B -
EV / Sales 2021 4,65x
EV / Sales 2022 4,35x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 163,62 $
Average target price 183,67 $
Spread / Average Target 12,3%
EPS Revisions
Managers and Directors
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON3.96%431 456
ROCHE HOLDING AG12.99%328 650
PFIZER, INC.7.61%220 661
NOVARTIS AG3.00%210 615
ABBVIE INC.7.05%202 639
ELI LILLY AND COMPANY31.15%202 413